Treatment of cancer with glufosfamide in patients not receiving insulin therapy
US8765690B2 · kind B2 · utility
0Cited by
11References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 7, 2008 |
| Grant date | Jul 1, 2014 |
| Priority date | — |
| Expiry date | Jun 9, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The co-administration of glufosfamide and a glucose lowering drug other than insulin is efficacious in cancer treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.